Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy

Identifieur interne : 000458 ( PascalFrancis/Corpus ); précédent : 000457; suivant : 000459

Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy

Auteurs : Stéphane Vignes ; Raphael Porcher ; Maria Arrault ; Alain Dupuy

Source :

RBID : Pascal:07-0325056

Descripteurs français

English descriptors

Abstract

Background Treatment of lymphedema is based on intensive decongestive physiotherapy followed by a long-term maintenance treatment. We analyzed the factors influencing lymphedema volume during maintenance treatment. Method Prospective cohort of 537 patients with secondary arm lymphedema were recruited in a single lymphology unit and followed for 12 months. Lymphedema volume was recorded prior to and at the end of intensive treatment, and at month 6 and month 12 follow-up visits. Multivariate models were fitted to analyze the respective role of the three components of complete decongestive therapy, i.e. manual lymph drainage, low stretch bandage, and elastic sleeve, on lymphedema volume during the 1-year maintenance phase therapy. Results Mean volume of lymphedema was 1,054 ± 633 ml prior and 647 ± 351 ml after intensive decongestive physiotherapy. During the 1-year maintenance phase therapy, the mean lymphedema volume slightly increased (84 ml-95% confidence interval [CI]: 56-113). Fifty-two percent of patients had their lymphedema volume increased above 10% from their value at the end of the intensive decongestive physiotherapy treatment phase. Non-compliance to low stretch bandage and elastic sleeve were risk factors for an increased lymphedema after 1-year of maintenance treatment (RR: 1.55 [95% CI: 1.3-1.76]; P < 0.0001 and RR: 1.61 (95% CI: 1.25-1.82); P = 0.002, respectively). Non-compliance to MLD was not a risk factor (RR: 0.99 [95% CI: 0.77-1.2]; P = 0.91). Conclusion During maintenance phase after intensive decongestive physiotherapy, compliance to the use of elastic sleeve and low stretch bandage should be required to stabilize lymphedema volume.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0167-6806
A02 01      @0 BCTRD6
A03   1    @0 Breast cancer res. treat.
A05       @2 101
A06       @2 3
A08 01  1  ENG  @1 Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy
A11 01  1    @1 VIGNES (Stéphane)
A11 02  1    @1 PORCHER (Raphael)
A11 03  1    @1 ARRAULT (Maria)
A11 04  1    @1 DUPUY (Alain)
A14 01      @1 Department of Lymphology, Hôpital Cognacq-Jay, Site Broussais, 102 rue Didot @2 75014 Paris @3 FRA @Z 1 aut. @Z 3 aut.
A14 02      @1 Department of Biostatistics and Medical Informatics, Hopital Saint-Louis AP-HP, Université Paris 7, Inserm U717 @2 Paris @3 FRA @Z 2 aut.
A14 03      @1 Department of Dermatology 2, Hôpital Saint Louis AP-HP, 1 Avenue Claude Vellefaux @2 75475 Paris @3 FRA @Z 4 aut.
A20       @1 285-290
A21       @1 2007
A23 01      @0 ENG
A43 01      @1 INIST @2 20699 @5 354000149916580050
A44       @0 0000 @1 © 2007 INIST-CNRS. All rights reserved.
A45       @0 28 ref.
A47 01  1    @0 07-0325056
A60       @1 P @3 C
A61       @0 A
A64 01  1    @0 Breast cancer research and treatment
A66 01      @0 NLD
C01 01    ENG  @0 Background Treatment of lymphedema is based on intensive decongestive physiotherapy followed by a long-term maintenance treatment. We analyzed the factors influencing lymphedema volume during maintenance treatment. Method Prospective cohort of 537 patients with secondary arm lymphedema were recruited in a single lymphology unit and followed for 12 months. Lymphedema volume was recorded prior to and at the end of intensive treatment, and at month 6 and month 12 follow-up visits. Multivariate models were fitted to analyze the respective role of the three components of complete decongestive therapy, i.e. manual lymph drainage, low stretch bandage, and elastic sleeve, on lymphedema volume during the 1-year maintenance phase therapy. Results Mean volume of lymphedema was 1,054 ± 633 ml prior and 647 ± 351 ml after intensive decongestive physiotherapy. During the 1-year maintenance phase therapy, the mean lymphedema volume slightly increased (84 ml-95% confidence interval [CI]: 56-113). Fifty-two percent of patients had their lymphedema volume increased above 10% from their value at the end of the intensive decongestive physiotherapy treatment phase. Non-compliance to low stretch bandage and elastic sleeve were risk factors for an increased lymphedema after 1-year of maintenance treatment (RR: 1.55 [95% CI: 1.3-1.76]; P < 0.0001 and RR: 1.61 (95% CI: 1.25-1.82); P = 0.002, respectively). Non-compliance to MLD was not a risk factor (RR: 0.99 [95% CI: 0.77-1.2]; P = 0.91). Conclusion During maintenance phase after intensive decongestive physiotherapy, compliance to the use of elastic sleeve and low stretch bandage should be required to stabilize lymphedema volume.
C02 01  X    @0 002B20E02
C02 02  X    @0 002B12B04
C03 01  X  FRE  @0 Long terme @5 01
C03 01  X  ENG  @0 Long term @5 01
C03 01  X  SPA  @0 Largo plazo @5 01
C03 02  X  FRE  @0 Traitement @5 02
C03 02  X  ENG  @0 Treatment @5 02
C03 02  X  SPA  @0 Tratamiento @5 02
C03 03  X  FRE  @0 Conduite à tenir @5 03
C03 03  X  ENG  @0 Clinical management @5 03
C03 03  X  SPA  @0 Actitud médica @5 03
C03 04  X  FRE  @0 Lymphoedème @5 04
C03 04  X  ENG  @0 Lymphedema @5 04
C03 04  X  SPA  @0 Linfedema @5 04
C03 05  X  FRE  @0 Physiothérapie @5 05
C03 05  X  ENG  @0 Physiotherapy @5 05
C03 05  X  SPA  @0 Fisioterapia @5 05
C03 06  X  FRE  @0 Observance @5 06
C03 06  X  ENG  @0 Compliance @5 06
C03 06  X  SPA  @0 Observancia @5 06
C03 07  X  FRE  @0 Cancer du sein @4 CD @5 96
C03 07  X  ENG  @0 Breast cancer @4 CD @5 96
C03 07  X  SPA  @0 Cáncer de pecho @4 CD @5 96
C07 01  X  FRE  @0 Tumeur maligne @5 37
C07 01  X  ENG  @0 Malignant tumor @5 37
C07 01  X  SPA  @0 Tumor maligno @5 37
C07 02  X  FRE  @0 Glande mammaire pathologie @2 NM @5 38
C07 02  X  ENG  @0 Mammary gland diseases @2 NM @5 38
C07 02  X  SPA  @0 Glándula mamaria patología @2 NM @5 38
C07 03  X  FRE  @0 Appareil circulatoire pathologie @5 39
C07 03  X  ENG  @0 Cardiovascular disease @5 39
C07 03  X  SPA  @0 Aparato circulatorio patología @5 39
C07 04  X  FRE  @0 Lymphatique pathologie @5 40
C07 04  X  ENG  @0 Lymphatic vessel disease @5 40
C07 04  X  SPA  @0 Linfático patología @5 40
N21       @1 211
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 07-0325056 INIST
ET : Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy
AU : VIGNES (Stéphane); PORCHER (Raphael); ARRAULT (Maria); DUPUY (Alain)
AF : Department of Lymphology, Hôpital Cognacq-Jay, Site Broussais, 102 rue Didot/75014 Paris/France (1 aut., 3 aut.); Department of Biostatistics and Medical Informatics, Hopital Saint-Louis AP-HP, Université Paris 7, Inserm U717/Paris/France (2 aut.); Department of Dermatology 2, Hôpital Saint Louis AP-HP, 1 Avenue Claude Vellefaux/75475 Paris/France (4 aut.)
DT : Publication en série; Compte-rendu; Niveau analytique
SO : Breast cancer research and treatment; ISSN 0167-6806; Coden BCTRD6; Pays-Bas; Da. 2007; Vol. 101; No. 3; Pp. 285-290; Bibl. 28 ref.
LA : Anglais
EA : Background Treatment of lymphedema is based on intensive decongestive physiotherapy followed by a long-term maintenance treatment. We analyzed the factors influencing lymphedema volume during maintenance treatment. Method Prospective cohort of 537 patients with secondary arm lymphedema were recruited in a single lymphology unit and followed for 12 months. Lymphedema volume was recorded prior to and at the end of intensive treatment, and at month 6 and month 12 follow-up visits. Multivariate models were fitted to analyze the respective role of the three components of complete decongestive therapy, i.e. manual lymph drainage, low stretch bandage, and elastic sleeve, on lymphedema volume during the 1-year maintenance phase therapy. Results Mean volume of lymphedema was 1,054 ± 633 ml prior and 647 ± 351 ml after intensive decongestive physiotherapy. During the 1-year maintenance phase therapy, the mean lymphedema volume slightly increased (84 ml-95% confidence interval [CI]: 56-113). Fifty-two percent of patients had their lymphedema volume increased above 10% from their value at the end of the intensive decongestive physiotherapy treatment phase. Non-compliance to low stretch bandage and elastic sleeve were risk factors for an increased lymphedema after 1-year of maintenance treatment (RR: 1.55 [95% CI: 1.3-1.76]; P < 0.0001 and RR: 1.61 (95% CI: 1.25-1.82); P = 0.002, respectively). Non-compliance to MLD was not a risk factor (RR: 0.99 [95% CI: 0.77-1.2]; P = 0.91). Conclusion During maintenance phase after intensive decongestive physiotherapy, compliance to the use of elastic sleeve and low stretch bandage should be required to stabilize lymphedema volume.
CC : 002B20E02; 002B12B04
FD : Long terme; Traitement; Conduite à tenir; Lymphoedème; Physiothérapie; Observance; Cancer du sein
FG : Tumeur maligne; Glande mammaire pathologie; Appareil circulatoire pathologie; Lymphatique pathologie
ED : Long term; Treatment; Clinical management; Lymphedema; Physiotherapy; Compliance; Breast cancer
EG : Malignant tumor; Mammary gland diseases; Cardiovascular disease; Lymphatic vessel disease
SD : Largo plazo; Tratamiento; Actitud médica; Linfedema; Fisioterapia; Observancia; Cáncer de pecho
LO : INIST-20699.354000149916580050
ID : 07-0325056

Links to Exploration step

Pascal:07-0325056

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy</title>
<author>
<name sortKey="Vignes, Stephane" sort="Vignes, Stephane" uniqKey="Vignes S" first="Stéphane" last="Vignes">Stéphane Vignes</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, Site Broussais, 102 rue Didot</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Porcher, Raphael" sort="Porcher, Raphael" uniqKey="Porcher R" first="Raphael" last="Porcher">Raphael Porcher</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Biostatistics and Medical Informatics, Hopital Saint-Louis AP-HP, Université Paris 7, Inserm U717</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Arrault, Maria" sort="Arrault, Maria" uniqKey="Arrault M" first="Maria" last="Arrault">Maria Arrault</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, Site Broussais, 102 rue Didot</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Dupuy, Alain" sort="Dupuy, Alain" uniqKey="Dupuy A" first="Alain" last="Dupuy">Alain Dupuy</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Dermatology 2, Hôpital Saint Louis AP-HP, 1 Avenue Claude Vellefaux</s1>
<s2>75475 Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">07-0325056</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0325056 INIST</idno>
<idno type="RBID">Pascal:07-0325056</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000458</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy</title>
<author>
<name sortKey="Vignes, Stephane" sort="Vignes, Stephane" uniqKey="Vignes S" first="Stéphane" last="Vignes">Stéphane Vignes</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, Site Broussais, 102 rue Didot</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Porcher, Raphael" sort="Porcher, Raphael" uniqKey="Porcher R" first="Raphael" last="Porcher">Raphael Porcher</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Biostatistics and Medical Informatics, Hopital Saint-Louis AP-HP, Université Paris 7, Inserm U717</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Arrault, Maria" sort="Arrault, Maria" uniqKey="Arrault M" first="Maria" last="Arrault">Maria Arrault</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, Site Broussais, 102 rue Didot</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Dupuy, Alain" sort="Dupuy, Alain" uniqKey="Dupuy A" first="Alain" last="Dupuy">Alain Dupuy</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Dermatology 2, Hôpital Saint Louis AP-HP, 1 Avenue Claude Vellefaux</s1>
<s2>75475 Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
<imprint>
<date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Breast cancer</term>
<term>Clinical management</term>
<term>Compliance</term>
<term>Long term</term>
<term>Lymphedema</term>
<term>Physiotherapy</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Long terme</term>
<term>Traitement</term>
<term>Conduite à tenir</term>
<term>Lymphoedème</term>
<term>Physiothérapie</term>
<term>Observance</term>
<term>Cancer du sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background Treatment of lymphedema is based on intensive decongestive physiotherapy followed by a long-term maintenance treatment. We analyzed the factors influencing lymphedema volume during maintenance treatment. Method Prospective cohort of 537 patients with secondary arm lymphedema were recruited in a single lymphology unit and followed for 12 months. Lymphedema volume was recorded prior to and at the end of intensive treatment, and at month 6 and month 12 follow-up visits. Multivariate models were fitted to analyze the respective role of the three components of complete decongestive therapy, i.e. manual lymph drainage, low stretch bandage, and elastic sleeve, on lymphedema volume during the 1-year maintenance phase therapy. Results Mean volume of lymphedema was 1,054 ± 633 ml prior and 647 ± 351 ml after intensive decongestive physiotherapy. During the 1-year maintenance phase therapy, the mean lymphedema volume slightly increased (84 ml-95% confidence interval [CI]: 56-113). Fifty-two percent of patients had their lymphedema volume increased above 10% from their value at the end of the intensive decongestive physiotherapy treatment phase. Non-compliance to low stretch bandage and elastic sleeve were risk factors for an increased lymphedema after 1-year of maintenance treatment (RR: 1.55 [95% CI: 1.3-1.76]; P < 0.0001 and RR: 1.61 (95% CI: 1.25-1.82); P = 0.002, respectively). Non-compliance to MLD was not a risk factor (RR: 0.99 [95% CI: 0.77-1.2]; P = 0.91). Conclusion During maintenance phase after intensive decongestive physiotherapy, compliance to the use of elastic sleeve and low stretch bandage should be required to stabilize lymphedema volume.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0167-6806</s0>
</fA01>
<fA02 i1="01">
<s0>BCTRD6</s0>
</fA02>
<fA03 i2="1">
<s0>Breast cancer res. treat.</s0>
</fA03>
<fA05>
<s2>101</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>VIGNES (Stéphane)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>PORCHER (Raphael)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>ARRAULT (Maria)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>DUPUY (Alain)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Lymphology, Hôpital Cognacq-Jay, Site Broussais, 102 rue Didot</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Biostatistics and Medical Informatics, Hopital Saint-Louis AP-HP, Université Paris 7, Inserm U717</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Department of Dermatology 2, Hôpital Saint Louis AP-HP, 1 Avenue Claude Vellefaux</s1>
<s2>75475 Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20>
<s1>285-290</s1>
</fA20>
<fA21>
<s1>2007</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20699</s2>
<s5>354000149916580050</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>28 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>07-0325056</s0>
</fA47>
<fA60>
<s1>P</s1>
<s3>C</s3>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Breast cancer research and treatment</s0>
</fA64>
<fA66 i1="01">
<s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Background Treatment of lymphedema is based on intensive decongestive physiotherapy followed by a long-term maintenance treatment. We analyzed the factors influencing lymphedema volume during maintenance treatment. Method Prospective cohort of 537 patients with secondary arm lymphedema were recruited in a single lymphology unit and followed for 12 months. Lymphedema volume was recorded prior to and at the end of intensive treatment, and at month 6 and month 12 follow-up visits. Multivariate models were fitted to analyze the respective role of the three components of complete decongestive therapy, i.e. manual lymph drainage, low stretch bandage, and elastic sleeve, on lymphedema volume during the 1-year maintenance phase therapy. Results Mean volume of lymphedema was 1,054 ± 633 ml prior and 647 ± 351 ml after intensive decongestive physiotherapy. During the 1-year maintenance phase therapy, the mean lymphedema volume slightly increased (84 ml-95% confidence interval [CI]: 56-113). Fifty-two percent of patients had their lymphedema volume increased above 10% from their value at the end of the intensive decongestive physiotherapy treatment phase. Non-compliance to low stretch bandage and elastic sleeve were risk factors for an increased lymphedema after 1-year of maintenance treatment (RR: 1.55 [95% CI: 1.3-1.76]; P < 0.0001 and RR: 1.61 (95% CI: 1.25-1.82); P = 0.002, respectively). Non-compliance to MLD was not a risk factor (RR: 0.99 [95% CI: 0.77-1.2]; P = 0.91). Conclusion During maintenance phase after intensive decongestive physiotherapy, compliance to the use of elastic sleeve and low stretch bandage should be required to stabilize lymphedema volume.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B20E02</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Long terme</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Long term</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Largo plazo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Conduite à tenir</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Clinical management</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Actitud médica</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Lymphoedème</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Lymphedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Linfedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Physiothérapie</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Physiotherapy</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Fisioterapia</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Observance</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Compliance</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Observancia</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Cancer du sein</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Breast cancer</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Cáncer de pecho</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Tumeur maligne</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Malignant tumor</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Tumor maligno</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Glande mammaire pathologie</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Appareil circulatoire pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Lymphatique pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Lymphatic vessel disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Linfático patología</s0>
<s5>40</s5>
</fC07>
<fN21>
<s1>211</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 07-0325056 INIST</NO>
<ET>Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy</ET>
<AU>VIGNES (Stéphane); PORCHER (Raphael); ARRAULT (Maria); DUPUY (Alain)</AU>
<AF>Department of Lymphology, Hôpital Cognacq-Jay, Site Broussais, 102 rue Didot/75014 Paris/France (1 aut., 3 aut.); Department of Biostatistics and Medical Informatics, Hopital Saint-Louis AP-HP, Université Paris 7, Inserm U717/Paris/France (2 aut.); Department of Dermatology 2, Hôpital Saint Louis AP-HP, 1 Avenue Claude Vellefaux/75475 Paris/France (4 aut.)</AF>
<DT>Publication en série; Compte-rendu; Niveau analytique</DT>
<SO>Breast cancer research and treatment; ISSN 0167-6806; Coden BCTRD6; Pays-Bas; Da. 2007; Vol. 101; No. 3; Pp. 285-290; Bibl. 28 ref.</SO>
<LA>Anglais</LA>
<EA>Background Treatment of lymphedema is based on intensive decongestive physiotherapy followed by a long-term maintenance treatment. We analyzed the factors influencing lymphedema volume during maintenance treatment. Method Prospective cohort of 537 patients with secondary arm lymphedema were recruited in a single lymphology unit and followed for 12 months. Lymphedema volume was recorded prior to and at the end of intensive treatment, and at month 6 and month 12 follow-up visits. Multivariate models were fitted to analyze the respective role of the three components of complete decongestive therapy, i.e. manual lymph drainage, low stretch bandage, and elastic sleeve, on lymphedema volume during the 1-year maintenance phase therapy. Results Mean volume of lymphedema was 1,054 ± 633 ml prior and 647 ± 351 ml after intensive decongestive physiotherapy. During the 1-year maintenance phase therapy, the mean lymphedema volume slightly increased (84 ml-95% confidence interval [CI]: 56-113). Fifty-two percent of patients had their lymphedema volume increased above 10% from their value at the end of the intensive decongestive physiotherapy treatment phase. Non-compliance to low stretch bandage and elastic sleeve were risk factors for an increased lymphedema after 1-year of maintenance treatment (RR: 1.55 [95% CI: 1.3-1.76]; P < 0.0001 and RR: 1.61 (95% CI: 1.25-1.82); P = 0.002, respectively). Non-compliance to MLD was not a risk factor (RR: 0.99 [95% CI: 0.77-1.2]; P = 0.91). Conclusion During maintenance phase after intensive decongestive physiotherapy, compliance to the use of elastic sleeve and low stretch bandage should be required to stabilize lymphedema volume.</EA>
<CC>002B20E02; 002B12B04</CC>
<FD>Long terme; Traitement; Conduite à tenir; Lymphoedème; Physiothérapie; Observance; Cancer du sein</FD>
<FG>Tumeur maligne; Glande mammaire pathologie; Appareil circulatoire pathologie; Lymphatique pathologie</FG>
<ED>Long term; Treatment; Clinical management; Lymphedema; Physiotherapy; Compliance; Breast cancer</ED>
<EG>Malignant tumor; Mammary gland diseases; Cardiovascular disease; Lymphatic vessel disease</EG>
<SD>Largo plazo; Tratamiento; Actitud médica; Linfedema; Fisioterapia; Observancia; Cáncer de pecho</SD>
<LO>INIST-20699.354000149916580050</LO>
<ID>07-0325056</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000458 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000458 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:07-0325056
   |texte=   Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024